Assessment of Frizzled 6 membrane mobility by FRAP supports G protein coupling and reveals WNT-Frizzled selectivity

Cellular Signalling

Volumn 26, Issue 9, 2014, Pages 1943-1949

  Kilander, Michaela B C ^a   Dahlström, Jenny ^a   Schulte, Gunnar ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Class Frizzled; Fluorescence recovery after photobleaching; GPCRs; Heterotrimeric G proteins; WNT signaling

Indexed keywords

FRIZZLED 6; FRIZZLED PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; WNT1 PROTEIN; WNT10B PROTEIN; WNT11 PROTEIN; WNT2 PROTEIN; WNT3A PROTEIN; WNT4 PROTEIN; WNT5A PROTEIN; WNT5B PROTEIN; WNT7A PROTEIN; WNT9B PROTEIN; FZD6 PROTEIN, HUMAN; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; N ETHYLMALEIMIDE; ONCOPROTEIN; PERTUSSIS TOXIN; RECOMBINANT PROTEIN; WNT5A PROTEIN, HUMAN;

ARTICLE; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; HUMAN; HUMAN CELL; MEMBRANE TRANSPORT; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSPORT KINETICS; AGONISTS; CELL MEMBRANE; DRUG EFFECTS; GENETICS; HEK293 CELL LINE; METABOLISM; TOXICITY;

CELL MEMBRANE; ETHYLMALEIMIDE; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; FRIZZLED RECEPTORS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HEK293 CELLS; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; PERTUSSIS TOXIN; PROTO-ONCOGENE PROTEINS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84901848004     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2014.05.012     Document Type: Article

References (35)

1. Schulte G. Pharmacol. Rev. 2010, 62:632-667.
2. Angers S., Moon R.T. Nat. Rev. Mol. Cell Biol. 2009, 10:468-477.
3. Willert K., Nusse R. Cold Spring Harb. Perspect. Biol. 2012, 4:a007864.
4. Inestrosa N.C., Arenas E. Nat. Rev. Neurosci. 2010, 11:77-86.
5. Guo N., Hawkins C., Nathans J. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:9277-9281.
6. Chang H., Nathans J. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:E908-E917.
7. Cui C.Y., Klar J., Georgii-Heming P., Frojmark A.S., Baig S.M., Schlessinger D., Dahl N. J. Investig. Dermatol. 2013, 133:1990-1997.
8. Frojmark A.S., Schuster J., Sobol M., Entesarian M., Kilander M.B., Gabrikova D., Nawaz S., Baig S.M., Schulte G., Klar J., Dahl N. Am. J. Hum. Genet. 2011, 88:852-860.
9. Naz G., Pasternack S.M., Perrin C., Mattheisen M., Refke M., Khan S., Gul A., Simons M., Ahmad W., Betz R.C. Br. J. Dermatol. 2012, 166:1088-1094.
10. Raza S.I., Muhammad N., Khan S., Ahmad W. Br. J. Dermatol. 2013, 168:422-425.
11. De Marco P., Merello E., Rossi A., Piatelli G., Cama A., Kibar Z., Capra V. Hum. Mutat. 2012, 33:384-390.
12. Stuebner S., Faus-Kessler T., Fischer T., Wurst W., Prakash N. Dev. Dyn. 2010, 239:246-260.
13. Hendrickx M., Leyns L. Dev. Growth Differ. 2008, 50:229-243.
14. Pucadyil T.J., Kalipatnapu S., Harikumar K.G., Rangaraj N., Karnik S.S., Chattopadhyay A. Biochemistry 2004, 43:15852-15862.
15. Sauliere-Nzeh Ndong A., Millot C., Corbani M., Mazeres S., Lopez A., Salome L. J. Biol. Chem. 2010, 285:14514-14520.
16. Cezanne L., Lecat S., Lagane B., Millot C., Vollmer J.Y., Matthes H., Galzi J.L., Lopez A. J. Biol. Chem. 2004, 279:45057-45067.
17. Katanaev V.L., Buestorf S. Nature Precedings 2009, (hdl:10101/npre.2009.2765.1).
18. Kilander M.B.C., Dijksterhuis J.P., Ganji R.S., Bryja V., Schulte G. Cell. Signal. 2011, 23:550-554.
19. Halleskog C., Dijksterhuis J.P., Kilander M.B., Becerril-Ortega J., Villaescusa J.C., Lindgren E., Arenas E., Schulte G. J. Neuroinflammation 2012, 9:111.
20. Kikuchi A., Yamamoto H., Sato A., Matsumoto S. Acta Physiol. (Oxf.) 2012, 204:17-33.
21. Jockers R., Linder M.E., Hohenegger M., Nanoff C., Bertin B., Strosberg A.D., Marullo S., Freissmuth M. J. Biol. Chem. 1994, 269:32077-32084.
22. Schulte G., Fredholm B.B. Cell. Signal. 2003, 15:813-827.
23. Hoshino S.-I., Kikkawa S., Takahashi K., Itoh H., Kaziro Y., Kawasaki H., Suzuki K., Katada T., Ui M. FEBS Lett. 1990, 276:227-231.
24. Sunyer T., Monastirsky B., Codina J., Birnbaumer L. Mol. Endocrinol. 1989, 3:1115-1124.
25. Dijksterhuis J.P., Petersen J., Schulte G. Br. J. Pharmacol. 2013, 171:1195-1209.
26. Koval A., Katanaev V.L. Drug Discov. Today 2012, 17:1316-1322.
27. Halleskog C., Schulte G. Cell. Signal. 2013, 25:822-828.
28. Kilander M.B.C., Halleskog C., Schulte G. Acta Physiol. 2011, 203:363-372.
29. Foord S.M., Bonner T.I., Neubig R.R., Rosser E.M., Pin J.P., Davenport A.P., Spedding M., Harmar A.J. Pharmacol. Rev. 2005, 57:279-288.
30. Wang H.Y., Liu T., Malbon C.C. Cell. Signal. 2006, 18:934-941.
31. Kilander M.B., Petersen J., Andressen K.W., Ganji R.S., Levy F.O., Schuster J., Dahl N., Bryja V., Schulte G. FASEB J. 2014, 28:2293-2305.
32. Pucadyil T.J., Chattopadhyay A. Glycoconj. J. 2007, 24:25-31.
33. Kenakin T. J. Pharmacol. Exp. Ther. 2011, 336:296-302.
34. Lipp P.K.L. High-Throughput Screening in Drug Discovery 2006, 129-149. Wiley-VCH Verlag GmbH & Co. KGaA. J. Hüser (Ed.).
35. Phair R.D., Gorski S.A., Misteli T. Methods Enzymol. 2004, 375:393-414.